Bacopa monnieri (Linn.) Penn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | Herpestis monnieria (Linn.) H. B. & K. Moniera cuneifolia Michx. |
| Family | Scrophulariaceae. |
| Habitat | Throughout the plains of India in damp marshy areas. |
| English | Thyme-leaved Gratiola. |
| Ayurvedic | Braahmi, Aindri, Nirbraahmi, Kapotavankaa, Bhaarati, Darduradalaa, Matsyaakshaka, Shaaluraparni, Mandukaparni (also equated with Centella asiatica Linn., synonym Hydrocotyle asiatica Linn. Umbelliferae, Apiaceae). |
| Unani | Brahmi. |
| Siddha / Tamil | Piramivazhukkai, Neerbrami. |
| Folk | Jalaneem, Safed-Chammi. |
| Action | Adaptogenic, astringent, diuretic, sedative, potent nervine tonic, anti-anxiety agent (improves mental functions, used in insanity, epilepsy), antispasmodic (used in bronchitis, asthma and diarrhoea). |
| Key Application | In psychic disorders and as a brain tonic. (The Ayurvedic Pharmacopoeia of India; Indian Herbal Pharmacopoeia.) |
| Dosage | Whole plant—1–3 g powder. (API Vol. II.) |
| Taxonomic Cohort | Genus Bacopa (1 documented species); Family Scrophulariaceae (19 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Bacopa monnieri (taxonomically cited with authority (Linn.) Penn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Scrophulariaceae (primary family classification: Scrophulariaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy Herpestis monnieria (Linn.) H. B. & K. Moniera cuneifolia Michx, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Throughout the plains of India in damp marshy areas.
Across classical and vernacular Indian systems of medicine, Bacopa monnieri is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Thyme-leaved Gratiola; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Braahmi, Aindri, Nirbraahmi, Kapotavankaa, Bhaarati, Darduradalaa, Matsyaakshaka, Shaaluraparni, Mandukaparni (also equated with Centella asiatica Linn., synonym Hydrocotyle asiatica Linn. Umbelliferae, Apiaceae); in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Brahmi; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Piramivazhukkai, Neerbrami; in regional Indian folk and vernacular ethnobotany as Jalaneem, Safed-Chammi. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Bacopa monnieri are: Adaptogenic, astringent, diuretic, sedative, potent nervine tonic, anti-anxiety agent (improves mental functions, used in insanity, epilepsy), antispasmodic (used in bronchitis, asthma and diarrhoea). These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: In psychic disorders and as a brain tonic. (The Ayurvedic Pharmacopoeia of India; Indian Herbal Pharmacopoeia.).
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Bacopa monnieri establish the following evidence base: B. monnieri has been shown to cause prolonged elevated level of cerebral glutamic acid and a transient increase in GABA level. It is assumed that endogenous increase in brain glutamine may be helpful in the process of learning. The herb contains the alkaloids brahmine, herpestine, and a mixture of three bases. Brahmine is highly toxic; in therapeutic doses it resembles strychnine. The herb also contains the saponins, monnierin, hersaponin, bacosides A and B. Bacosides A and B possess haemolytic activity. Hersaponin is reported to possess cardiotonic and sedative properties. It was found, as in case of reserpene, to deplete nor-adrenaline and 5-HT content of the rat brain. An alcoholic extract of the plant in a dose of 50 mg/kg produced tranquilizing effect on albino rats and dogs, but the action was weaker than that produced by chlorpromazine.
In specialized pharmacognostic classifications, Bacopa monnieri is also listed among standardized commercial herbal extracts used in India with defined quantitative phytochemical markers; and represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

Figure 1: Authenticated crude herb specimen — Bacopa monnieri leaf.

Botanical Reference 1: Bacopa monnieri — Botanical specimen

Botanical Reference 2: Bacopa monnieri — Botanical specimen

Botanical Reference 3: Bacopa monnieri — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Bacopa monnieri stands as a distinct representative of the genus Bacopa. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Scrophulariaceae encompasses 19 documented medicinal species (1.05% of the 1,814-species flora). Other representative medicinal members of Scrophulariaceae include: Digitalis lanata (Hritpatri), Digitalis purpurea (Hritpatri), Euphrasia simplex (Eyebright), Limnophila aromatica (Aamragandha Karpuur), Lindenbergia indica (Haldi Basanto). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 2: Quantitative documentation profile across all 19 medicinal species of family Scrophulariaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Bacopa monnieri are prescribed as follows: Whole plant—1–3 g powder. (API Vol. II.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Bacopa monnieri integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.